Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial

被引：0
作者：
Ferguson, G. T. [1 ]
Rabe, K. F. [2 ,3 ,4 ]
Martinez, F. J.
Wang, C. [5 ]
Singh, D. [6 ,7 ]
Wedzicha, J. [8 ]
Trivedi, R. [9 ]
Rose, E. [9 ]
Ballal, S. [9 ]
McLaren, J. [9 ]
Darken, P. [9 ]
Aurivillius, M. [9 ]
Reisner, C. [9 ]
Dorinsky, P. [9 ]
机构：
[1] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[2] Lungenclin Grosshansdorf GmbH, Grosshansdorf, Germany
[3] Zentrum Pneumol & Thoraxchirurg, Grosshansdorf, Germany
[4] Deutsch Zentrum Lungenforsch DZL, Airway Res Ctr North Arcn, Neuherberg, Germany
[5] China Japan Friendship Hosp, Beijing Key Lab Resp & Pulm Circulat Disorders, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[6] Med Evaluat Unit Ltd, Manchester, Lancs, England
[7] Univ Manchester, Manchester, Lancs, England
[8] Imperial Coll London, Natl Herz & Lungeninst, London, England
[9] AstraZeneca, Cambridge, England
来源：
PNEUMOLOGIE | 2021年 / 75卷
关键词：
D O I：
10.1055/s-0041-1723287
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [41] Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study
    Kerwin, Edward M.
    Ferguson, Gary T.
    Mo, Mindy
    DeAngelis, Kiernan
    Dorinsky, Paul
    [J]. RESPIRATORY RESEARCH, 2019, 20 (1):
  • [42] Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study
    Edward M. Kerwin
    Gary T. Ferguson
    Mindy Mo
    Kiernan DeAngelis
    Paul Dorinsky
    [J]. Respiratory Research, 20
  • [43] Efficacy and safety of budesonide/formoterol fumarate dihydrate metered dose inhaler (BFF MDI) using co-suspension delivery technology compared to monocomponents and an active comparator in COPD
    Ferguson, Gary T.
    Papi, Alberto
    Anzueto, Antonio
    Kerwin, Edward M.
    Cappelletti, Christy
    Duncan, Elizabeth A.
    Nyberg, Jack
    Dorinsky, Paul
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
    Shigeo Muro
    Hisatoshi Sugiura
    Patrick Darken
    Paul Dorinsky
    [J]. Respiratory Research, 22
  • [45] Benefits of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) in Reducing Exacerbation Risk in Patients with Moderate-to-Very Severe COPD: A Pooled Analysis of the PINNACLE Studies
    Sethi, S.
    Lipworth, B. J.
    Ferguson, G. T.
    Arora, S.
    Jenkins, M.
    Maes, A.
    Martin, U. J.
    Reisner, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [46] Poor Metered-Dose-Inhaler (MDI) Technique as a Predictor of Inhaled Corticosteroid (ICS) Overuse in Chronic Obstructive Pulmonary Disease (COPD)
    Griffith, M.
    Feemster, L. C.
    Donovan, L. M.
    Spece, L.
    Krishnan, J. A.
    Lindenauer, P. K.
    McBurnie, M.
    Mularski, R. A.
    Au, D. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [47] Pharmacokinetics of Co-Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed-Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single-Dose, Crossover Study in Healthy Adults
    Maes, Andrea
    DePetrillo, Paolo
    Siddiqui, Shahid
    Reisner, Colin
    Dorinsky, Paul
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 223 - 233
  • [48] Pulmonary deposition of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler formulated using co-suspension delivery technology in healthy male subjects
    Israel, Samuel
    Kumar, Ashish
    DeAngelis, Kiernan
    Aurivillius, Magnus
    Dorinsky, Paul
    Roche, Nicolas
    Usmani, Omar S.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 153
  • [49] Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial
    Beeh, Kai-Michael
    Kuna, Piotr
    Corradi, Massimo
    Viaud, Isabelle
    Guasconi, Alessandro
    Georges, George
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 79 - 89
  • [50] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Symptoms of Chronic Obstructive Pulmonary Disease (COPD) in Patients with Moderate to Very Severe COPD
    Tashkin, D. P.
    Rennard, S. I.
    Ramachandran, S.
    Martin, P.
    Goldman, M.
    Martin, U. J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345